PL3949971T3 - Zastosowanie 7-o-glukozydu luteoliny lub 7-o-glukuronidu luteoliny w preparatach do leczenia urazów oka - Google Patents

Zastosowanie 7-o-glukozydu luteoliny lub 7-o-glukuronidu luteoliny w preparatach do leczenia urazów oka

Info

Publication number
PL3949971T3
PL3949971T3 PL19922400.7T PL19922400T PL3949971T3 PL 3949971 T3 PL3949971 T3 PL 3949971T3 PL 19922400 T PL19922400 T PL 19922400T PL 3949971 T3 PL3949971 T3 PL 3949971T3
Authority
PL
Poland
Prior art keywords
luteolin
glucuronide
glucoside
medicine
preparation
Prior art date
Application number
PL19922400.7T
Other languages
English (en)
Inventor
Hao Wang
Xuexiang CHENG
Original Assignee
Beijing Chengyi Investment Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Chengyi Investment Co., Ltd. filed Critical Beijing Chengyi Investment Co., Ltd.
Publication of PL3949971T3 publication Critical patent/PL3949971T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
PL19922400.7T 2019-04-04 2019-08-20 Zastosowanie 7-o-glukozydu luteoliny lub 7-o-glukuronidu luteoliny w preparatach do leczenia urazów oka PL3949971T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910271900.2A CN110025625A (zh) 2019-04-04 2019-04-04 木犀草素-7-o-葡萄糖苷或木犀草素-7-o-葡萄糖醛酸苷在制备眼损伤药物的应用
PCT/CN2019/101567 WO2020199460A1 (zh) 2019-04-04 2019-08-20 木犀草素-7-o-葡萄糖苷或木犀草素-7-o-葡萄糖醛酸苷在制备眼损伤药物的应用

Publications (1)

Publication Number Publication Date
PL3949971T3 true PL3949971T3 (pl) 2024-10-14

Family

ID=67237504

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19922400.7T PL3949971T3 (pl) 2019-04-04 2019-08-20 Zastosowanie 7-o-glukozydu luteoliny lub 7-o-glukuronidu luteoliny w preparatach do leczenia urazów oka

Country Status (16)

Country Link
US (1) US12383573B2 (pl)
EP (1) EP3949971B1 (pl)
JP (1) JP7281227B2 (pl)
CN (1) CN110025625A (pl)
DK (1) DK3949971T3 (pl)
ES (1) ES2987258T3 (pl)
FI (1) FI3949971T3 (pl)
HR (1) HRP20241182T1 (pl)
HU (1) HUE068007T2 (pl)
LT (1) LT3949971T (pl)
PL (1) PL3949971T3 (pl)
PT (1) PT3949971T (pl)
RS (1) RS65797B1 (pl)
SI (1) SI3949971T1 (pl)
SM (1) SMT202400352T1 (pl)
WO (1) WO2020199460A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110025625A (zh) * 2019-04-04 2019-07-19 北京诚毅投资股份有限公司 木犀草素-7-o-葡萄糖苷或木犀草素-7-o-葡萄糖醛酸苷在制备眼损伤药物的应用
CN112641758A (zh) * 2020-12-30 2021-04-13 深圳市墨脱生物科技有限责任公司 阻抗蓝光的组合物及其制备方法和应用
CN112546040A (zh) * 2020-12-31 2021-03-26 杭州电子科技大学 山奈酚在制备防护蓝光损伤的保健食品或药物中的应用
CN120718879B (zh) * 2025-07-16 2026-02-13 广州优然生物科技有限公司 一种通过定向进化方法获得的葡萄糖基转移酶及其衍生物、应用和制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
KR100903030B1 (ko) * 2007-08-23 2009-06-18 주식회사 안지오랩 멜리사엽 추출물 분획 및 이를 포함하는 조성물
CN102512433A (zh) * 2011-11-09 2012-06-27 沈阳双鼎科技有限公司 木犀草素-7-O-β-D-葡萄糖醛酸苷治疗眼底病用途
CN103933058B (zh) * 2014-04-24 2016-02-03 上海中医药大学附属岳阳中西医结合医院 木犀草素-7-二葡萄糖醛酸苷在制备治疗视网膜退行性病变药物中的应用
CN106074585B (zh) 2016-06-29 2019-01-11 上海中医药大学附属岳阳中西医结合医院 人参皂苷Rb1和Rd组合及其在制备治疗光感受器细胞死亡相关疾病的药物中的应用
CN106880626A (zh) 2017-03-14 2017-06-23 何伟 山奈酚在制备预防和治疗视网膜损伤性疾病药物中的应用
CN108159143B (zh) * 2017-12-08 2021-01-01 沈阳眼产业技术研究院有限公司 覆盆子提取物在制备预防和治疗视网膜损伤性疾病药物中的应用
CN108938687B (zh) 2018-09-03 2021-06-25 辽宁何氏医学院 蒺藜在制备预防和治疗视网膜损伤性疾病药物中的应用
CN110025625A (zh) 2019-04-04 2019-07-19 北京诚毅投资股份有限公司 木犀草素-7-o-葡萄糖苷或木犀草素-7-o-葡萄糖醛酸苷在制备眼损伤药物的应用
CN109876003B (zh) 2019-04-04 2022-02-08 湖北明钼健康科技有限公司 木犀草素-7-o-葡萄糖苷、木犀草素-7-o-葡萄糖醛酸苷的制药新应用

Also Published As

Publication number Publication date
EP3949971A1 (en) 2022-02-09
JP2022530750A (ja) 2022-07-01
SMT202400352T1 (it) 2024-11-15
SI3949971T1 (sl) 2024-10-30
EP3949971A4 (en) 2022-12-21
DK3949971T3 (da) 2024-08-12
HRP20241182T1 (hr) 2024-11-22
WO2020199460A1 (zh) 2020-10-08
LT3949971T (lt) 2024-08-26
FI3949971T3 (fi) 2024-08-30
EP3949971B1 (en) 2024-06-26
CN110025625A (zh) 2019-07-19
US20220160742A1 (en) 2022-05-26
PT3949971T (pt) 2024-09-10
HUE068007T2 (hu) 2024-12-28
RS65797B1 (sr) 2024-08-30
ES2987258T3 (es) 2024-11-14
JP7281227B2 (ja) 2023-05-25
US12383573B2 (en) 2025-08-12

Similar Documents

Publication Publication Date Title
HUE065585T2 (hu) Integrált sebészeti rendszer a szem szivárványhártya-szaruhártya szögletének kezelésére
PL3577135T3 (pl) Kompozycja farmaceutyczna do stosowania do leczenia lub zapobiegania chorobom związanym z c5
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
EP3310356A4 (en) Compositions for the improvement of distance vision and the treatment of refractive errors of the eye
SI3676285T1 (sl) Cepivo za uporabo pri profilaksi in/ali zdravljenju bolezni
EP3137116A4 (en) Dendrimer compositions and their use in treatment of diseases of the eye
HUE068007T2 (hu) Luteolin-7-O-glükozid vagy luteolin-7-O-glükuronid alkalmazása szem sérülésekhez való gyógyszer elõállításában
IL282504A (en) Ocular formulations for drug administration and protection of the front part of the eye
EP3187189A4 (en) Composition and medicinal product for reducing body weight and body fat, and use of said product
IL274578A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
HUE067057T2 (hu) Gyógyszerkészítmény C5-tel kapcsolatos betegség kezelésében vagy megelõzésében történõ alkalmazásra
IL273470A (en) Semaglutide in medical treatment
EP3015111A4 (en) Use of chinese medicine preparation in preparing drug for preventing and/or treating crohn's disease
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PT3193832T (pt) Preparação viscoelástica para utilização em métodos cirúrgicos de cirurgia oftálmica.
IL272495A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
GB2558494B (en) Protein nanostructure based drug delivery system for the delivery of therapeutic agents to the anterior segment of the eye
ZA201804198B (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
EP3253311A4 (en) Scaffolds for the treatment of spinal cord injuries and diseases
HK40026666A (en) Semaglutide in medical therapy
GB201718838D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
GB201712742D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
HK1231747A1 (en) Dendrimer compositions and their use in treatment of diseases of the eye